Introduction
Approximately 2.7 million surgical procedures are performed each year in the UK, with approximately 4% of patients undergoing non-cardiac surgery dying in hospitals postoperatively [1, 2] , and an even larger proportion developing postoperative complications [3] . Although the causes are multifactorial, it is believed that tissue hypoperfusion and the imbalance between oxygen delivery and oxygen consumption plays a significant role [4, 5] . Achieving haemodynamic stability and ensuring adequate oxygen delivery in the perioperative period is therefore of paramount importance and is a core component in the provision of anaesthesia. In recent years there has been increased interest and implementation of goal-directed therapy (GDT) with the use of minimally invasive haemodynamic monitors to improve tissue oxygen delivery [6] .
Haemodynamic monitoring describes the 'realtime' measurement of cardiovascular variables and dynamic parameters of fluid responsiveness to guide administration of intravenous fluids, vasopressors and inotropic therapy [7] . Over the last few decades, there have been significant advancements in the development of less invasive technology and increased availability which, coupled with a large body of evidence showing reduced mortality and complications, has led to the concept of GDT becoming significantly embedded in clinical practice [8, 9] . No single device exists at present that is able to provide the clinician with a complete and 100% accurate evaluation of cardiovascular status, and each monitor is associated with its own benefits and limitations. Recent evidence, however, has cast doubt on the beneficial effects of GDT and the gap between the supporting evidence for its use and its implementation in clinical practice is wider than ever.
This review will revisit the physiological rationale for GDT, and discuss the most commonly-used haemodynamic monitoring devices and variables used in clinical care, with a focus on the most recent evidence. It will also look at how current practice has evolved and what the future for GDT and haemodynamic monitoring holds.
Brief history
In the 1980s, using data from the pulmonary artery flotation catheter (PAC), Shoemaker et al. noted higher postoperative indices of oxygen delivery and reduced oxygen debt in survivors of major surgery compared with non-survivors [10] [11] [12] . When these higher indices found in survivors were used as targets, they found an improvement in survival. Later studies similarly showed that patients with increased oxygen delivery indices were more likely to survive major surgery, and that measuring oxygen delivery could predict postoperative outcome [10, 11] . Shoemaker et al. subsequently hypothesised that attainment of 'supranormal' physiological parameters; a cardiac output of > 4.5 l.min.m 2 , oxygen delivery of > 600 ml.min.m 2 and oxygen consumption of > 170 ml.min.m 2 would be associated with improved survival after major surgery. Drawing on this hypothesis, other studies went on to demonstrate that using a PAC-based protocol with fluids and inotropic support and reducing the 'oxygen debt' significantly decreased mortality and organ failure in high-risk non-cardiac surgical patients [10, 13] . However, over time, observational data showed an association between use of the PAC and increased mortality in the ITU. At the same time, evidence started to emerge that targeting supranormal values with a PAC yielded no benefit over standard care in elderly surgical patients when started late or when high dose of vasoactive drugs were used [14, 15] .
With the focus trending away from PACs, researchers started to develop novel methods of optimising the cardiovascular system using fluids to target stroke volume (SV) and inotropes to target cardiac output and oxygen delivery. Less invasive haemodynamic monitors were developed in parallel to the implementation of peri-operative protocols. These protocols aimed to optimise cardiac output with fluids, and in some protocols with inotropes, to increase oxygen delivery, in order to compensate for the increased metabolic response of major surgery. With a growing body of evidence, further minimally invasive haemodynamic monitors were developed and the practice of GDT progressed.
Haemodynamic monitoring and variables
Traditionally, anaesthetists have used parameters such as heart rate (HR), blood pressure (BP), central venous pressure (CVP) and urine output to guide their perioperative care, but although readily available, these variables have consistently shown to be neither sensitive or specific enough to provide an accurate evaluation of the cardiovascular status as a whole [16] . Both HR and CVP have been proven to be inaccurate indicators of volume status [17] , and research has shown that the relationship between arterial pressure, ventricular stroke volume and venous return is non-linear, thereby preventing the arterial pressure from being used as an endpoint for cardiac output monitoring and optimisation [18] [19] [20] .
Central venous pressure has previously been used to guide peri-operative fluid therapy, but a CVP of between 5 mmHg to 20 mmHg has certainly almost no predictive value, and changes in CVP with a fluid bolus have not been shown to be predictive of fluid status [21] . Central venous pressure is well-known to be affected by other variables, such as intrathoracic pressure, venous resistance and pulmonary vascular resistance, and a recent study demonstrated that there is little value in using CVP as a marker of adequate systemic oxygen delivery after major surgery [22] .
Both central and mixed venous oxygen saturations (Scv0 2, Sv0 2 ) have been used as markers to reflect on the balance between oxygen delivery and oxygen consumption, with an increased oxygen consumption proportional to delivery resulting in decreased values. Although Sv0 2 has not been well-studied outside of cardiac surgery [23] , Scv0 2 has been shown to be associated with reduced morbidity and length of stay in patients undergoing abdominal surgery [24] .
Various haemodynamic monitors are currently clinically available, each associated with their own benefits and limitations. Additionally, each monitor will vary in its accuracy and precision. In order to interpret the values generated by these monitors, clinicians need to understand how the circulation is regulated. One relevant approach is to consider how best to combine measurements of the different variables within a conceptual framework model of the circulation [25] . Guyton stated that the cardiac output and central venous pressure are determined by the interactions between both cardiac function and venous return to the heart. This is the focus of cardiovascular modelling [25] . Another approach is to consider the ability of a device to detect changes in cardiac output following a therapeutic intervention, particularly in haemodynamically unstable patients as this will have a direct impact on the therapeutic intervention [16, 26] . The analysis of the general trend over the specific measurement could also be argued as of greater clinical significance.
Cardiac output can be measured using invasive, minimally invasive and non-invasive devices, with the PAC enabling pulmonary artery thermodilution being the most invasive.
Pulmonary artery catheter
This is currently the gold standard monitor, with an estimated accuracy of 12-15% with triplicate injection of iced saline and poorer accuracy in obese or elderly patients [16, 27] . It allows for direct measurements of central venous, right-sided intracardiac, pulmonary arterial and pulmonary artery wedge pressures, and can estimate both systemic and pulmonary vascular resistance [7] . It also has a role in assessing whether the cardiac output is providing adequate oxygen delivery to meet the metabolic demands of the tissue, the basis for which GDT has been developed [7] . Unfortunately, PACs are unable to effectively predict fluid responsiveness using stroke volume variation (SVV), as the cardiac output is measured by thermodilution over a 15-s period. Additionally, its time lag makes it difficult to use when performing a fluid challenge with a small amount of fluid given in 5-10 min [28] .
Real-time monitoring of fluid responsiveness
Fluid responsiveness can be defined as an increase in SV or cardiac output by 10-15% in response to a fluid challenge, although the rate and volume of fluid is variable [21] . Fluid is titrated until it reaches the plateau of the Frank-Starling curve as seen in Fig. 1 [29] . In patients whose lungs are mechanically ventilated, the cyclical variations in SV and pulse pressure caused by the heart-lung interaction can be used to predict fluid responsiveness before giving fluids.
Pulse pressure analysis uses the arterial waveform to calculate cardiac output and SV, and can also calculate dynamic parameters such as stroke volume variation (SVV) and pulse pressure variation (PPV). Pulse pressure is dependent on the amount of blood ejected into the aorta and is thereby related to stroke volume. The arterial pressure waveform is, however, not directly proportional to SV and is related to the changes between SV and changes in vascular resistance, compliance and impedance [7] . Devices therefore use complex algorithms to analyse the pulse pressure and determine the SV and many of these devices require calibration. The PiCCO requires calibration with thermodilution, whereas the FloTrac uses the standard deviation of the arterial pulse pressure around the mean arterial pulse pressure and an auto calibration factor. The LiDCO TM plus uses pulse power analysis [7] . The FloTrac, since its introduction in 2005, has been continuously updated, and now integrates 'third-generation' software; studies have shown reasonable agreement with pulmonary artery thermodilution [30, 31] . Although it has not been extensively studied in GDT, there are limited data showing beneficial effects in reducing postoperative complications [32, 33] . The LiDCO plus technique stands for lithiumdiluted cardiac output, which, using pulse power analysis, converts the arterial waveform into a volume-time waveform to calculate cardiac output [24] . The LiDCO rapid system uses a nomogram to calculate the patient's specific aortic compliance, and therefore prior calibration with lithium dilution is not required [30] . The use of both LiDCO systems in peri-operative GDT have been extensively studied and evidence has demonstrated both reduced length of stay and postoperative outcomes [34] [35] [36] .
Various haemodynamic indices exist which have been used to predict fluid responsiveness and optimise the cardiovascular state. Pulse pressure variation values around 13% and SVV values around 10-13% accurately predict fluid responsiveness, with reported predictive values of more than 0.85 [37, 38] in patients whose lungs are mechanically ventilated in sinus rhythm without arrhythmias. This is in stark contrast to the 50% accuracy rate of a clinician to predict whether a patient is fluid responsive based on clinical criteria alone [37] . The pleth variability index (PVI) calculated with non-invasive monitoring has also proven to be effective in predicting fluid responsiveness [39] .
Intra-operative SVV-guided fluid optimisation has also been shown to decrease gastrointestinal complications in patients undergoing major abdominal surgery and reduce wound infections after high-risk surgery [39, 40] . Intra-operative PPV has additionally been proven to reduce duration of mechanical ventilation, morbidity and length of stay in non-cardiac, high-risk surgery [41] . Although the theoretical advantage of dynamic indices is that they reflect the changes in SV with changes in intrathoracic pressures, they are nonetheless associated with various limitations. Patients' lungs must be mechanically ventilated with a tidal volume of at least 6ml.kg
À1
, in sinus rhythm with a closed chest and normal abdominal pressures for these devices to accurately predict fluid responsiveness [16, 41, 42] . The effect of intrathoracic pressure on SV varies depending on the function of the left ventricle, and therefore PPV is not a useful indicator in these patients [43] . Pulse pressure variation is also affected by the presence of cardiac arrhythmias, peripheral vasoconstriction and the use of vasopressors [44] . It has also been demonstrated that despite being effective as a predictive marker, in up to 25% of patients, PPV can fall in the 'grey zone' between 9% and 13% making it difficult to determine if a patient is indeed fluid responsive [16] .
With regard to non-invasive devices, PVI is the most widely studied in GDT. The pleth variability index is calculated by measuring both the minimal and maximal plethysmographic waveform amplitudes and calculating the percentage difference [16] . Although there are various factors which will affect the waveform, there is evidence to suggest that it has reasonable reliability in predicting fluid responsiveness in patients undergoing anaesthesia, although further research is warranted [45] .
Oesophageal Doppler
The oesophageal Doppler monitor (ODM) and arterial pressure waveform analysis are the two most common minimally invasive methods of haemodynamic monitoring. The ODM, which uses the pulse-wave Doppler principle has gained in popularity, with increasing evidence showing that fluid optimisation with its use can improve patient outcome [45] [46] [47] . The oesophageal Doppler is inserted into the oesophagus of the anaesthetised patient at mid-thoracic level and calculates CO by measuring blood flow velocity in the descending aorta and using the cross-sectional diameter of the aorta, often using nomograms. In 2010, the British National Institute for Health and Care Excellence recommend its use in patients undergoing major or highrisk surgery-based primarily on the reduced length of hospital stay associated with the ODM [48] . However, this was a finding that was not reported in all the studies that NICE examined and of note, NICE only considered the results from eight randomised, controlled trials to formulate their guidance [49] . Additionally, many of the trials examined were single-centre studies with an 
Bioreactance
Another novel non-invasive method of measuring cardiac output is thoracic bioreactance. This is based on the application of a high-frequency transthoracic current and the analysis of variations of voltage in each heartbeat. The NICOM device is an example of this method and consists of four pads placed across the chest connected to a monitor. An advantage of this system is that it can be used in patients whose lungs are mechanically ventilated and in patients who are spontaneously breathing alike, and in the presence of cardiac arrhythmias [16] .
A recent study using bioimpedance technology in GDT demonstrated similar performance compared with the ODM, and studies have shown encouraging results regarding its precision compared with pulmonary artery thermodilution [50, 51] The use of electrocautery, however, interferes with the thoracic bioimpedance signal, making it unlikely that it will become a widely applicable device in the future, although, again, further research is necessary. An overview of the various devices used for haemodynamic monitoring and their benefits and limitations is shown in Table 1 [52] .
Evidence for goal-directed therapy
In recent years, the focus has moved away from 'maximisation' of cardiac output to 'optimisation' in the peri-operative period. Goal-directed therapy has been well-established as a standard of care in anaesthesia due to the strong body of evidence behind it and its benefits in reducing both morbidity and mortality [8, 53] . Although the majority of the evidence for GDT is centred around patients undergoing major gastrointestinal surgery, there is an increasing body of evidence for its use in orthopaedic [54] , cardiac [55, 56] and vascular surgery [57] . However, the last couple of years have seen a shift in the evidence, with recent studies showing little or no benefit of GDT in the peri-operative period, leading clinicians to question its clinical utility.
The OPTIMISE study is the largest study to date of peri-operative GDT and its results were published in 2014 [58] . It was a multicentre, randomised, blinded trial which enrolled 734 patients undergoing major abdominal surgery. The intervention group were monitored with calibrated waveform analysis and n/a n/a PVI CCO, continuous cardiac output; CVP, central venous pressure GEDV, global end-diastolic volume; EVLW, extravascular lung water; SVV, stroke volume variation, PPV, pulse pressure variation; PVI, pleth variability index.. underwent haemodynamic optimisation with colloid boluses and dopexamine infusion specifically targeting SV for the duration of the surgical procedure and 6 h postoperatively. Although the study showed there was no difference in mortality or postoperative complications at day 30, when a planned subanalysis was performed removing the first ten patients per site, a significant reduction in postoperative complications was demonstrated.
The POEMAS study, a multicentre, randomised trail also published in the same year, randomly allocated patients undergoing major abdominal surgery to noninvasive monitoring using chest bioreactance and a tailored haemodynamic protocol. Again there was no difference in mortality, length of stay or complications [59] .
More recently the POMO study was published in 2015, and this was also a multicentre, double-blind, randomised trial enrolling over 200 patients undergoing major elective surgery. The intervention was randomisation to a GDT protocol and specifically targeting the patient's pre-operative oxygen delivery values. Interestingly, the study demonstrated that those patients who were able to achieve their pre-operative oxygen delivery targets in the postoperative period sustained reduced morbidity and infectious complications [60] . As well as demonstrating a lack of benefit, deleterious effects have been seen in healthy aerobically fit patients undergoing major colorectal surgery receiving GDT by the development of volume overload [61] . Although this finding has not been reproduced by other studies, it is a significant observation that warrants further exploration in future studies.
Despite these negative trials, it is important to take into consideration that the care of the surgical patient in the peri-operative period has evolved significantly over the last few years. The progressive development of enhanced recovery after surgery (ERAS) programmes which encompass haemodynamic monitoring and GDT have altered what we think of as 'standard care' and it may be that 'best practice' has actually become 'standard care'. The ability to detect the effect of a single intervention has therefore been hampered. Other possibilities suggested by Cecconi and Rhodes are that the large body of evidence may have suffered from publication bias or that, as mentioned previously, it may be that there are harmful effects of SV optimisation such as volume overload which need further exploration [62] .
Despite recent negative evidence, there is still a future for GDT, but perhaps not in the manner originally or currently envisaged. Care of the peri-operative patient is continuously progressing and our understanding of cardiovascular physiology and prediction of fluid responsiveness has significantly evolved over the last few years. Implementation of peri-operative enhanced recovery programmes have taught us how to encompass bundles effectively in clinical care, and this will only continue to improve as these bundles become further embedded in 'standard care'. It may be that we no longer focus on specific haemodynamic variables per se but that we include GDT as part of a progressive peri-operative bundle. There are still many areas that warrant further research and further research studies comparing GDT with a control group will have to take the change in baseline care into account. As Pinsky noted: 'no monitoring device, no matter how simple or sophisticated, will improve patients outcome unless coupled to a treatment which itself improves outcome'. Therefore, the next challenge in the perioperative era will be to determine the right goals to target and integrate them into appropriate protocols which can be used to guide peri-operative care.
While there are some studies that have shown no increased benefit for GDT with minimally invasive techniques, most literature has consistently demonstrated a reduction in morbidity when applied to highrisk surgical patients [7, 9] .
Further developments
Other potential markers of haemodynamic status which are worthy of further research include vascular tone and the microcirculation. It is well-known by all anaesthetists that general anaesthesia influences vascular tone and therefore has a considerable effect on whether a patient is deemed to be 'preload or fluid responsive'. However, being preload responsive does not necessarily equate to a patient requiring extra fluid as this can be seen in healthy haemodynamically stable patients with adequate organ perfusion [63, 64] . It is important for the clinician to therefore assess whether a reduced mean arterial pressure under anaesthesia is due to a decreased vascular tone or inadequate blood flow.
Assessment of vasomotor tone using dynamic arterial elastance (Eadyn) may therefore be of clinical utility. Research has shown that when the arterial tone and ventricular systolic function is coupled, ventricular performance is maximised [65] . Eadyn is defined as the PPV to SVV ratio measured during a single positive breath and has been suggested to provide a functional assessment of arterial tone [62] . Eadyn has been shown to predict the response to a single fluid challenge in both patients whose lungs are mechanically ventilated and spontaneously breathing patients [66, 67] . The development of GDT protocols potentially incorporating the assessment of Eadyn in the future could have significant benefits in helping guide the clinician as to whether the first-line intervention should actually be fluid or whether a vasopressor is in fact required to restore vascular tone before further optimisation [62] .
Another potential area of interest is microcirculatory dysfunction. Although it has been extensively studied in the critical care setting, the evidence of its effect on peri-operative outcomes is currently lacking. Studies have shown that implementation of GDT is linked to improved microcirculatory flow in the perioperative period and that patients with poor oxygen delivery who had increased morbidity had an increased rate of microcirculatory dysfunction postoperatively [68, 69] . Although both assessment of Eadyn and microcirculatory dysfunction may be potential targets in the future of GDT, further research is warranted to specifically determine their effect on peri-operative outcomes.
Closed-loop systems for haemodynamic optimisation are another emerging development in GDT. These systems operate by tracking haemodynamic parameters such as HR, SV and MAP using software which allows the administration of fluid until the SV reaches the plateau of the Frank-Starling curve [70] . By monitoring SV and tracking SVV and PPV, the system aims to keep the haemodynamic status of the patient at the plateau of the curve for the duration of the surgical procedure. Although this system has been validated against trained anaesthetists in a simulated model, there is limited evidence to such its feasibility and applicability in routine clinical practice.
Conclusions
In conclusion, we have seen that the implementation of GDT with the use of minimally and less invasive monitors to guide peri-operative practice has become rapidly established and accepted over the last few years. Although recent evidence has cast some doubt over the beneficial effects, the majority of the literature has demonstrated improved morbidity and mortality in certain populations. Care of the peri-operative patient is continuously evolving and our standards of care have changed and this needs to be taken into account in future studies. Haemodynamic monitoring in the peri-operative period remains promising with exciting new areas emerging which are of potential interest in the future.
